FindTrial
Sign In

A retrospective study on the relationship between progesterone sensitivity and molecular expression in patients undergoing fertility-sparing treatment for endometrial carcinoma

A retrospective study on the relationship between progesterone sensitivity and molecular expression in patients undergoing fertility-sparing treatment for endometrial carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122240
Enrollment
Unknown
Registered
2026-04-10
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Control group:None
Case group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18–40 years; 2.Received fertility-preserving progesterone therapy; 3.Availability of complete immunohistochemical staining results for ER, PR, and Ki-67 from specimens collected before, during, and after treatment, along with complete follow-up data;

Exclusion criteria

Exclusion criteria: 1.Presence of other concurrent malignant tumors; 2.Receipt of other anti-tumor therapies during the treatment period; 3.Missing critical data;

Design outcomes

Primary

MeasureTime frame
Progesterone therapy sensitivity;—

Secondary

MeasureTime frame
Recurrent rate;Pregnancy rate;—

Countries

China

Contacts

Public ContactHongbo Wang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

hb_wang1969@sina.com+86 27 85726729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026